Which COVID studies pose a biohazard? Lack of clarity hampers research (original) (raw)

Controversy surrounding a study that involved modifying the SARS-CoV-2 virus has prompted researchers to call for better guidance from funders.

By

  1. Ewen Callaway
  2. Max Kozlov

When researchers at Boston University (BU) in Massachusetts inserted a gene from the Omicron variant of SARS-CoV-2 into a strain of the virus from the beginning of the pandemic, they were trying to understand why Omicron causes mild disease.

Access options

Access Nature and 54 other Nature Portfolio journals

Get Nature+, our best-value online-access subscription

$32.99 / 30 days

cancel any time

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Nature 611, 17-18 (2022)

doi: https://doi.org/10.1038/d41586-022-03344-w

References

Subjects

Latest on: